B. Hennemann

1.5k total citations
41 papers, 1.2k citations indexed

About

B. Hennemann is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, B. Hennemann has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in B. Hennemann's work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (10 papers) and Immune cells in cancer (10 papers). B. Hennemann is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (10 papers) and Immune cells in cancer (10 papers). B. Hennemann collaborates with scholars based in Germany, Canada and Israel. B. Hennemann's co-authors include Reinhard Andreesen, Stefan W. Krause, Torsten Tonn, Hans Klingemann, Guitta Maki, Ying K. Tam, Annegret Rehm, Connie J. Eaves, Jean Y. Chuo and R. Keith Humphries and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

B. Hennemann

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Hennemann Germany	20	478	424	374	189	159	41	1.2k
Carol J. Schlueter United States	6	282 0.6×	305 0.7×	324 0.9×	136 0.7×	89 0.6×	7	1.1k
A L Kariniemi Finland	17	288 0.6×	413 1.0×	630 1.7×	150 0.8×	101 0.6×	29	1.6k
Sivan Harel United States	13	305 0.6×	95 0.2×	529 1.4×	101 0.5×	121 0.8×	28	1.7k
Lies H. Jaspars Netherlands	11	278 0.6×	168 0.4×	286 0.8×	106 0.6×	32 0.2×	22	1.1k
Koichi Oshima Japan	17	333 0.7×	261 0.6×	357 1.0×	126 0.7×	75 0.5×	77	1.1k
P Stosiek Germany	19	180 0.4×	296 0.7×	644 1.7×	234 1.2×	140 0.9×	73	1.5k
Caroline Hutter Austria	15	350 0.7×	211 0.5×	363 1.0×	136 0.7×	52 0.3×	32	1.2k
Hitoshi Minamiguchi Japan	14	152 0.3×	156 0.4×	318 0.9×	169 0.9×	57 0.4×	38	910
Toshihiro Nagato Japan	25	1.0k 2.1×	864 2.0×	401 1.1×	83 0.4×	42 0.3×	81	1.6k
Saba Nayar United Kingdom	17	828 1.7×	534 1.3×	185 0.5×	166 0.9×	80 0.5×	42	1.4k

Countries citing papers authored by B. Hennemann

Since Specialization

Citations

This map shows the geographic impact of B. Hennemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Hennemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Hennemann more than expected).

Fields of papers citing papers by B. Hennemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Hennemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Hennemann. The network helps show where B. Hennemann may publish in the future.

Co-authorship network of co-authors of B. Hennemann

This figure shows the co-authorship network connecting the top 25 collaborators of B. Hennemann. A scholar is included among the top collaborators of B. Hennemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Hennemann. B. Hennemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grünwald, Viktor, Ulrich Keilholz, Andreas Boehm, et al.. (2014). TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO). Annals of Oncology. 26(3). 561–567. 52 indexed citations

Gauler, Thomas, Viktor Gruenwald, Axel Matzdorff, et al.. (2013). Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie. Oncology. 84(5). 284–289. 34 indexed citations

Boy, Sandra, Thorsten Schormann, Felix Schlachetzki, et al.. (2011). Mobilisation of Hematopoietic CD34+ Precursor Cells in Patients with Acute Stroke Is Safe - Results of an Open-Labeled Non Randomized Phase I/II Trial. PLoS ONE. 6(8). e23099–e23099. 29 indexed citations

Zellner, Johannes, Michael Mueller, Arne Berner, et al.. (2010). Role of mesenchymal stem cells in tissue engineering of meniscus. Journal of Biomedical Materials Research Part A. 94A(4). 1150–1161. 134 indexed citations

Grassinger, Jochen, et al.. (2008). EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells. Bone Marrow Transplantation. 43(3). 197–206. 11 indexed citations

Hennemann, B., Guntram W. Ickenstein, Sebastian Haas, et al.. (2008). Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy. 10(3). 303–311. 33 indexed citations

Hart, Christina, Christian U. Blank, Stefan W. Krause, Reinhard Andreesen, & B. Hennemann. (2007). Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide. Annals of Hematology. 86(8). 575–581. 3 indexed citations

Grassinger, Jochen, et al.. (2007). Bone morphogenetic protein (BMP)-7 but not BMP-2 and BMP-4 improves maintenance of primitive peripheral blood-derived hematopoietic progenitor cells (HPC) cultured in serum-free medium supplemented with early acting cytokines. Cytokine. 40(3). 165–171. 23 indexed citations

Grassinger, Jochen, et al.. (2006). Differentiation of hematopoietic progenitor cells towards the myeloid and B‐lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines. European Journal Of Haematology. 77(2). 134–144. 9 indexed citations

10.

Kunz‐Schughart, Leoni A., et al.. (2006). SCF modulates organ distribution and hematopoietic engraftment of CB-derived pluripotent HPC transplanted in NOD/SCID mice. Cytotherapy. 8(1). 70–78. 1 indexed citations

11.

Hennemann, B.. (2006). Palliative Chemotherapie von Kopf-Hals-Tumoren: Aktueller Stand und neue Entwicklungen. Laryngo-Rhino-Otologie. 85(3). 172–178. 8 indexed citations

12.

Bock, Jürgen, et al.. (2006). Pericarditis after High-Dose Chemotherapy: More Frequent than Expected?. Oncology Research and Treatment. 29(7). 321–324. 11 indexed citations

13.

Zaiß, Matthias, Michael Rehli, Annegret Rehm, et al.. (2003). CD84 expression on human hematopoietic progenitor cells. Experimental Hematology. 31(9). 798–805. 29 indexed citations

14.

Hennemann, B., Jean Y. Chuo, P Schley, et al.. (2000). High-Efficiency Retroviral Transduction of Mammalian Cells on Positively Charged Surfaces. Human Gene Therapy. 11(1). 43–51. 23 indexed citations

15.

Hennemann, B., Eibhlin Conneally, Robert Pawliuk, et al.. (1999). Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables. Experimental Hematology. 27(5). 817–825. 84 indexed citations

16.

Tam, Ying K., et al.. (1999). Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy. Human Gene Therapy. 10(8). 1359–1373. 176 indexed citations

17.

Hennemann, B., et al.. (1997). Adoptive Immunotherapy with Tumor-Cytotoxic Macrophages Derived from Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhuGM-CSF) Mobilized Peripheral Blood Monocytes. Journal of Immunotherapy. 20(5). 365–371. 25 indexed citations

18.

Marienhagen, Jörg, et al.. (1995). 111In-oxine labelling of tumour-cytotoxic macrophages generated in vitro from circulating blood monocytes. Nuclear Medicine Communications. 16(5). 357–361. 14 indexed citations

19.

Hennemann, B., et al.. (1995). Intrahepatic Adoptive Immunotherapy with Autologous Tumorcytotoxic Macrophages in Patients with Cancer. Journal of Immunotherapy. 18(1). 19–27. 23 indexed citations

20.

Andreesen, Reinhard & B. Hennemann. (1991). Adoptive Immunotherapy with Autologous Macrophages: Current Status and Future Perspectives. Pathobiology. 59(4). 259–263. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact